Draegerwerk AG & Co. KGaA (0MT8) Share Price & Analysis
0MT8 Stock Chart & Stats
- Day’s Range
- EUR 75.80 - EUR 78.00
- 52-Week Range
- EUR 55.20 - EUR 95.80
- Previous Close
- EUR 76.60
- Volume
- 0
- Average Volume (3M)
- 522
- Market Cap
- EUR 1.64B
- Enterprise Value
- EUR 1.68B
- Total Cash (Recent Filing)
- EUR 270.90M
- Total Debt (Recent Filing)
- EUR 228.93M
- Price to Earnings (P/E)
- 11.3
- Beta
- 0.69
- Next Earnings
- Mar 17, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- May 11, 2026
- Dividend Yield
- 2.92%
Bulls Say, Bears Say
Bulls Say
Recovery In Growth And Cash Generation
The sharp improvement in revenue, operating cash flow and free cash flow indicates that Dräger has rebuilt operating momentum after the 2022 trough. Stronger internal cash generation can support investment, debt reduction and customer support while improving resilience over the next several quarters.
Safety Division Momentum
Safety is delivering broad-based order, sales and profit growth across product areas and regions, giving Dräger a profitable earnings engine alongside Medical. Continued momentum in detection and respiratory protection can support group margins and diversify performance over the medium term.
FDA Warning Letter Lifted
Removal of the FDA warning letter is a structural regulatory improvement that eliminates a long-running operational burden and enables Dräger to benefit more fully from product approvals. It may also improve execution capacity and commercial credibility in Medical over time.
Bears Say
Medical Remains Loss-making
Medical has improved but still consumes earnings capacity rather than contributing positive operating profit. Continued losses in a core segment could restrain group margin expansion, limit the benefit of revenue growth and require sustained execution before profitability becomes durable.
Cost Pressure Threatens Margin Sustainability
Expense growth above the pace of some operating improvements creates a persistent risk to margin conversion. Higher personnel, logistics, IT and freight costs can absorb gross-profit gains, making the confirmed EBIT target more dependent on disciplined spending and execution.
Weak China Demand
China is an important market opportunity for Dräger, yet current demand is below expectations and local competitors are also cutting spending. Prolonged weakness could delay Medical recovery, reduce regional growth contributions and require additional commercial investment to rebuild momentum.
0MT8 FAQ
What was Draegerwerk AG & Co. KGaA’s price range in the past 12 months?
What is Draegerwerk AG & Co. KGaA’s market cap?
When is Draegerwerk AG & Co. KGaA’s upcoming earnings report date?
How were Draegerwerk AG & Co. KGaA’s earnings last quarter?
Is Draegerwerk AG & Co. KGaA overvalued?
Does Draegerwerk AG & Co. KGaA pay dividends?
What is Draegerwerk AG & Co. KGaA’s EPS estimate?
How many shares outstanding does Draegerwerk AG & Co. KGaA have?
What happened to Draegerwerk AG & Co. KGaA’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Draegerwerk AG & Co. KGaA?
What is the TipRanks Smart Score and how is it calculated?
Draegerwerk AG & Co. KGaA Stock Smart Score
Company Description
Draegerwerk AG & Co. KGaA
Headquartered in Lübeck, Germany, and established in 1889, Drägerwerk AG & Co. KGaA is a global provider of advanced medical and safety technology solutions. The company serves a diverse international clientele across Europe, the Americas, Africa, Asia, and Australia. Within the medical field, Drägerwerk develops and markets comprehensive system solutions, equipment, and support services tailored for acute care environments. This encompasses emergency services, surgical procedures (perioperative care), intensive care units (critical care), and specialized newborn care (perinatal care). Their extensive product portfolio includes items such as anesthesia machines, respiratory ventilators, temperature management devices, monitoring systems for patients, and associated software and consumables. For safety applications, the company delivers essential products, integrated systems, and services designed for personal protection, sophisticated gas detection, and holistic hazard management. These offerings cater to industrial and mining operations, as well as public safety organizations like fire brigades, police forces, and disaster relief agencies. Key safety products range from fixed and portable gas sensing equipment to personal protective gear and devices for alcohol and drug screening. Furthermore, Drägerwerk extends its expertise through various training programs, comprehensive service packages, and even dedicated fire training facilities for emergency responders.
- Sector
- General
- Industry
- Medical - Devices
- CEO
- Stefan A. Drager
- Employees
- 16,687
- Website
- www.draeger.com
- Address
- Moislinger Allee 53-55, Lübeck, SH, 23542, DE
Draegerwerk AG & Co. KGaA (0MT8) Earnings & Revenues
0MT8 Earnings Call
Earnings Call SentimentPositive
The call was predominantly positive. Dräger reported strong nine-month order intake, sales, earnings, cash flow, balance-sheet improvement and Safety division momentum, confirmed full-year guidance, and highlighted the lifting of the FDA warning letter and opportunities in defense. These positives were tempered by third-quarter EBIT and Medical performance declines, higher functional expenses, a negative net tariff effect, weaker China demand, Americas and APAC pressure in specific areas, and the need for tight fourth-quarter cost management.
View all GB:0MT8 earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 5 | 10 |
| Technical Analysis | 2 | 5 | 3 |
| Moving Averages | 5 | 0 | 7 |